Silo Pharma (SILO) said the Canadian Intellectual Property Office issued a Notice of Allowance for a patent application covering its lead candidate SPC-15. This advances the company’s intellectual property position and supports future protection of its technology, though it is not yet a commercial milestone.
Silo Pharma (SILO) said the Canadian Intellectual Property Office issued a Notice of Allowance for a patent application covering its lead candidate SPC-15. This advances the company’s intellectual property position and supports future protection of its technology, though it is not yet a commercial milestone.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
